The following guidelines are excerpted from Palumbo et al, International Myeloma Working Group Guidelines for the Management of Multiple Myeloma Patients Ineligible for Standard High-Dose Chemotherapy with Autologous Stem Cell Transplantation, Leukemia (2009), 1-15.
The most important feature of any clinical unit established to care for myeloma patients is the training and expertise of the medical staff. Below are the diagnostic and specialty services required to support treatment decision-making and patient management. Patient support services, though desirable hallmarks of a good specialty center, are not absolutely essential.
- It is recommended that a special clinical unit be developed devoted to the treatment of MM, with clear policies and protocols for access to specific therapies and supportive services.
- A minimum of two newly diagnosed patients per month should receive induction therapy to ensure appropriate skill and experience of health personnel.
Required expertise and services for management of patients with MM